Market Place
Sourcing Support
Cipher Enters into Co-Promotion Agreement with Verity Pharmaceuticals
10 Feb 2021 //
INVESTORROOM
Cipher Enters into Co-Promotion Agreement with Verity Pharmaceuticals
10 Feb 2021 //
INVESTORROOM
Cipher Pharma`s Receives Health Canada Approval For Trulance® (Plecanatide)
19 Oct 2019 //
BIOSPACE
Arog Lands OPDP Statements for Investigational Drug
11 Jul 2018 //
RAPS
Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals
15 May 2018 //
PR NEWSWIRE
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals
28 Feb 2018 //
PRESS RELEASE
With only 2 warnings in 2017, pharma`s ad police at historic low
14 Nov 2017 //
FIERCE PHARMA
Cipher Pharmaceuticals Adds New Vice President of Corporate Development
03 Jun 2017 //
NEWS WIRE
Former Celgene (CELG) Exec to Helm Cipher Pharma (DND.TO)
21 Mar 2017 //
BIOSPACE
Cipher Pharma introduces Beteflam in Canadian market to treat plaque psoriasis.
06 Apr 2016 //
PHARMABIZ
Sun Pharma gains on patent litigation settlement with Actavis
06 Oct 2015 //
BUSINESS STANDARD
Cipher Pharmaceuticals Announces U.S. Commercial Entry Through Acquisition of INNOCUTIS
14 Apr 2015 //
CIPHER PHARMACEUTICALS INC
Cipher Pharma Buys Canadian Rights to Novel Treatment for Psoriasis and RA from Can-Fite Biopharma
24 Mar 2015 //
PHARMABIZ
Health Canada Accepts Cipher Pharma`s Beteflam Patch for Review
14 Feb 2015 //
CIPHER PHARMACEUTICALS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.